Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H12BrFN4 |
| Molecular Weight | 371.206 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NN=C2CN=C(C3=CC(Br)=CC=C3N12)C4=C(F)C=CC=C4
InChI
InChIKey=VXGSZBZQCBNUIP-UHFFFAOYSA-N
InChI=1S/C17H12BrFN4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-8H,9H2,1H3
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-Flubromazolam
Created by
admin on Sat Dec 16 10:24:56 GMT 2023 , Edited by admin on Sat Dec 16 10:24:56 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID40620266
Created by
admin on Sat Dec 16 10:24:56 GMT 2023 , Edited by admin on Sat Dec 16 10:24:56 GMT 2023
|
PRIMARY | |||
|
1BF1HN5GWD
Created by
admin on Sat Dec 16 10:24:56 GMT 2023 , Edited by admin on Sat Dec 16 10:24:56 GMT 2023
|
PRIMARY | |||
|
612526-40-6
Created by
admin on Sat Dec 16 10:24:56 GMT 2023 , Edited by admin on Sat Dec 16 10:24:56 GMT 2023
|
PRIMARY | |||
|
21930924
Created by
admin on Sat Dec 16 10:24:56 GMT 2023 , Edited by admin on Sat Dec 16 10:24:56 GMT 2023
|
PRIMARY | |||
|
100000164920
Created by
admin on Sat Dec 16 10:24:56 GMT 2023 , Edited by admin on Sat Dec 16 10:24:56 GMT 2023
|
PRIMARY | |||
|
SUB179556
Created by
admin on Sat Dec 16 10:24:56 GMT 2023 , Edited by admin on Sat Dec 16 10:24:56 GMT 2023
|
PRIMARY | |||
|
FLUBROMAZOLAM
Created by
admin on Sat Dec 16 10:24:56 GMT 2023 , Edited by admin on Sat Dec 16 10:24:56 GMT 2023
|
PRIMARY | Flubromazolam is a benzodiazepine derivative closely related to triazolam and flubromazepam that has been sold online as a designer drug. Flubromazolam is reputed to be highly potent, and concerns have been raised that clonazolam and flubromazolam in particular may pose comparatively higher risks than other designer benzodiazepines, due to their ability to produce strong sedation and amnesia at oral doses of as little as 0.5mg.[5] Life-threatening adverse reactions have been observed at doses of only 3mg of flubromazolam. |
ACTIVE MOIETY
